Clinical Trial Results Support Genetic Testing of All Patien

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced findings from its PROCLAIM trial, published in European Urology...

Related Keywords

Myrtle Beach , South Carolina , United States , American , W Michael Korn , Amanda Mcquery , Linkedin Invitae , American Cancer Society , Exchange Commission , Invitae Corporation , Carolina Urologic Research Center , National Comprehensive Cancer Network , European Urology Oncology , Urology Oncology , Neal Shore , Private Securities Litigation Reform Act , Quarterly Report ,